Plastic Surgery Marketing
Agency in India.
Backed by App\Support\NamedExperts::get(). --}}
Plastic surgery is the most compliance-restricted category in Indian healthcare marketing. Section 6 of the NMC Professional Conduct Regulations governs personal advertising for every surgeon on the register, ASCI's guidelines add a second filter on outcome and superiority claims, and Meta's global Personal Attributes policy blocks the "Before/After" creative style that most first-time aesthetic marketers try to run. On top of that, the buyer's consideration cycle is 30 to 180 days, the purchase is emotional, and the patient is often researching in private mode from a personal handset. Marketing to that patient without triggering a takedown, an ASCI notice or an NMC complaint is a very specific craft. This page is the operator's manual for that craft — the funnel design, the CPQL matrix, the platform rules and the engagement model ICG uses with plastic surgeons and aesthetic groups across India.
Long consult. Decision-heavy.
And under three regulators at once.
Every other elective category in Indian healthcare — LASIK, dental implants, IVF, hair transplant — has one regulator to satisfy and a purchase decision measured in weeks. Plastic surgery has three regulators, a purchase decision measured in months, and a patient who wants the entire enquiry to remain confidential. That combination sits behind almost every marketing mistake the category makes.
The consult cycle is long. Rhinoplasty, breast augmentation, face-lift and mummy-makeover buyers routinely first search 90 to 180 days before booking their consult. They save Instagram Reels quietly, follow four to seven surgeons at once, and never engage publicly. The moment they book a consult is preceded by an average of 40+ passive impressions from the winning practice. Digital that is only bottom-of-funnel misses this buyer entirely.
The decision is emotional and privacy-guarded. Unlike LASIK where the patient will happily post a "day 1 without glasses" Reel, most plastic surgery patients never tell anyone they had the procedure. The review-generation SOP, patient-story architecture and testimonial mechanics that work everywhere else in healthcare do not work here. A different, consent-heavy craft is required.
The regulatory stack has three layers. NMC's Section 6 forbids personal advertising that names the surgeon in a self-promotional way, testimonials from patients, and outcome guarantees. ASCI's code, applied by broadcasters and Meta, adds "no misleading advertisement" and "no denigration of alternatives" filters. Meta's Personal Attributes policy — enforced by machine review before a human ever sees the creative — blocks any ad copy or image implying negative self-perception based on body attributes. The Before/After grid, the "get the body you want" hook and the "target problem areas" copy all trigger this filter at the ad-review stage.
ICG's plastic surgery playbook is built around these three constraints — not against them. The compliance framework is a moat, not a burden: surgeons who set up their digital infrastructure correctly compete on trust and consult experience, while surgeons who try to shortcut the rules burn ad accounts, take down landing pages, and reset progress every quarter.
Seven verticals.
Seven different funnels.
"Plastic surgery" is not one market. It is a stack of sub-verticals with different buyers, different search behaviours, different consult cycles and very different ad-policy exposure. A pillar strategy that treats it as one bucket underperforms every time.
The most decision-heavy aesthetic procedure in India
Two intents run in parallel — aesthetic rhinoplasty and functional septorhinoplasty. Aesthetic buyers are 22-35, urban, comparison-heavy, and research 3D imaging content and revision-rhinoplasty case philosophy before they book. Functional buyers arrive via ENT co-referral. CPQL band: ₹2,500 to ₹6,000. See the rhinoplasty operator's manual for the full breakdown.
Technique-differentiated content plays
The buyer has already watched 20+ Reels about VASER, SmartLipo, tumescent and Renuvion by the time they contact the practice. They arrive with a technique preference. Practices that publish technique-explainer content in the surgeon's voice, and that publish realistic recovery expectation content, win the consult. See liposuction and body contouring.
Implant-brand education + privacy-guarded intake
India's most privacy-sensitive aesthetic funnel. Implant education (silicone vs saline, smooth vs textured, round vs anatomical, Motiva vs Mentor category education, not brand comparison) drives the top of the funnel; a WhatsApp intake with explicit privacy language handles bottom-of-funnel. See breast augmentation.
The 45+ aesthetic buyer with a longer consideration window
This buyer is not on Reels the way a 28-year-old rhinoplasty patient is. Long-form Instagram carousels, YouTube surgeon explainers, and a formalised dermatology co-referral network drive most of the funnel. Non-surgical alternative content (threads, HIFU, Ulthera) is a top-of-funnel entry point, not a competitor. See face-lift marketing.
India's highest-search-volume male aesthetic
Gynaecomastia has an outsized search index in India — the search volume across "man boobs treatment," "gyno surgery cost," and related male-body queries exceeds most aesthetic sub-verticals combined. The funnel is discretion-first: incognito browsing, WhatsApp intake, no visible testimonials. See gynaecomastia marketing.
B2B referral vertical, not a search vertical
Belt lipectomy, panniculectomy, brachioplasty and thigh lifts happen 12 to 24 months after weight-loss surgery. The pipeline is built through bariatric-surgeon partnerships, not Google Ads. The GLP-1 wave (Ozempic and Mounjaro) is adding a new, adjacent patient pool from 2025 onward. See post-bariatric marketing.
Nobody books surgery online.
Design for the consult instead.
The biggest strategic error a plastic surgery practice can make is treating the website as a booking engine. No plastic surgery patient in India books a rhinoplasty online. They book a consult. The consult is where the surgeon assesses candidacy, sets expectations, agrees a plan and quotes a price. That is the conversion event we are optimising for — not the surgery itself.
Touch 1 — passive discovery. A saved Reel, a followed Instagram handle, a YouTube surgeon explainer, an AI Overview snippet. Zero data captured. Zero pressure. This stage runs for 30 to 90 days and the practice does not know it is happening.
Touch 2 — comparison research. The patient starts Googling. Reads three or four surgeon pages, watches technique-comparison videos, hunts down credential detail. This is where the website earns or loses trust — credential density, memberships (APSI, IAAPS, ISAPS), fellowship logos and technique explainers matter more than testimonials at this stage.
Touch 3 — enquiry. WhatsApp, form or phone. Privacy language is critical — "your enquiry is confidential; we don't call your phone unless you ask us to" moves the enquiry rate by a measurable margin. Auto-response speed under 5 minutes, and human follow-up under 4 hours, are the two variables that predict consult-book rates.
Touch 4 — consult. Consult book-to-completion rate is where money leaks. Practices without a coordinator lose 25 to 40% of booked consults to no-shows. Practices with a dedicated aesthetic patient coordinator, a pre-consult confirmation SOP and a WhatsApp reminder cadence show up to 90%+.
Touch 5 — surgery decision. Aesthetic surgery decision windows are 2 to 12 weeks from consult. The nurture between consult and decision is where 60% of long-cycle wins land — patients who did not book in the room but came back after a further Reel viewing session, a follow-up call, or a second opinion.
ICG builds all five touches into the retainer. The website is Touch 2. The Instagram and YouTube content is Touch 1 and Touch 5. The WhatsApp funnel and coordinator SOP is Touch 3 and Touch 4. Every one of these is measured separately.
Three regulators.
One compliant creative stack.
NMC Section 6 (Professional Conduct Regulations 2002, still active). Plastic surgeons on the National Medical Commission register cannot solicit patients through advertising that names the practitioner in a way that promises superiority, guarantees an outcome, or uses patient testimonials as marketing. What is allowed: factual disclosure of qualifications, sub-specialty focus, hospital affiliations, published research and educational content. This is what makes surgeon-led educational content the compliant creative primitive for the entire category.
ASCI overlay. The Advertising Standards Council of India applies its Code to healthcare creative through platform enforcement (Meta and Google both act on ASCI-flagged material). ASCI's live filters include claims of "best," "leading," "number one," "risk-free," and any denigration of alternative practitioners or techniques. ICG's creative-review checklist scrubs these terms before every ad goes live.
Meta Personal Attributes policy. This is the one that catches first-time aesthetic advertisers off guard. Meta's automated ad-review reads copy for phrases that assume or imply the viewer's negative self-perception based on their body — "tired of your belly fat?" "get the body you want" "hate what you see in the mirror?" Every one of these is disallowed. Creative that assumes an active, informed interest in a specific procedure ("if you're researching rhinoplasty, here's what to ask at a consult") passes. Creative that pushes body dissatisfaction fails.
Before/After creative. This is where operators most often break. Meta's global aesthetic surgery policy explicitly disallows the classic Before/After side-by-side format. Even a compliant medical intent behind it does not pass automated review. NMC also frowns on outcome imagery. The workaround is not to hide outcomes — it is to reframe: consent-guarded educational imagery showing anatomy, technique, or process; surgeon-narrated technique explainers; and third-party editorial coverage that references outcomes at population level.
Plastic surgery CPQL — market vs ICG portfolio.
ICG data, rolling 12 months.
| Procedure | Market avg CPQL | ICG portfolio CPQL | Consult-book rate | Consult to case rate |
|---|---|---|---|---|
| Rhinoplasty | ₹3,500-₹8,000 | ₹2,500-₹6,000 | 32-48% | 18-28% |
| Liposuction | ₹2,500-₹6,500 | ₹1,800-₹4,500 | 35-52% | 22-32% |
| Breast augmentation | ₹4,500-₹10,000 | ₹3,000-₹7,500 | 28-42% | 16-24% |
| Face-lift | ₹5,000-₹12,000 | ₹3,500-₹8,500 | 30-45% | 14-22% |
| Gynaecomastia | ₹1,800-₹4,500 | ₹1,200-₹3,000 | 42-58% | 28-38% |
| Body contouring (combined) | ₹3,000-₹7,500 | ₹2,200-₹5,500 | 30-45% | 20-30% |
| Post-bariatric body | Referral-led | Referral-led | 60-75% | 35-45% |
Source: ICG portfolio data, rolling 12 months (Sep 2025-Aug 2026), n=9 plastic surgery engagements. Market averages informed by Industry healthcare marketing benchmarks and ISAPS India chapter operator surveys.
The economics that matter to the practice principal are further down this table than most operators realise. A ₹2,500 CPQL means nothing if the consult book rate is 12% and the case conversion is 8%. A ₹4,500 CPQL with a 45% book rate and a 28% case rate is the more profitable stack. ICG's optimisation lens sits at the case-cost line — ₹ per booked and completed surgery — not the CPQL line alone.
Compliance is where most agencies fail.
Healthcare advertising in India sits at the intersection of NMC (registered medical practitioners), DPDP Act (patient data), and ASCI (advertising standards). Generalist marketing agencies routinely violate one or more.
No comparative claims without published data. Patient testimonials require DPDP consent. Advertising must match the specialist's registered scope.
NMC / ASCI enforcement action + potential takedown of advertising accounts
Every ad + landing page + email routed through a compliance checkpoint before publishing. Zero enforcement actions across 150+ healthcare clients since 2018.
NMC Ethics Code 2026 · DPDP Act 2023 · ART (Regulation) Act 2021 · NABH 6th Edition · Dental Council of India · Schedule J (drug advertising) · UCPMP 2024 · ASCI Healthcare Guidelines
Compliance interpretations current as of September 2026. Enforcement bulletins tracked weekly by ICG's compliance research desk. See our editorial standards for how we source and update these.
Three channels that carry the category.
Each with its own compliance rule.
The primary trust channel — Reels-first, surgeon-authored
Plastic surgery is the specialty where Instagram outperforms Google as a top-of-funnel trust channel. But only if the content is surgeon-authored, technique-explanatory, and compliance-safe. A three-Reel-a-week cadence in the surgeon's voice, focused on candidacy criteria, technique differences, recovery reality and consult experience, outperforms a five-Reel-a-week cadence made by an agency intern with stock footage.
Compliance rules on Reels: no before/after grids, no outcome guarantees, no denigration of alternatives, no direct patient testimonials as marketing. What is allowed: educational anatomy, technique explainers, consent-guarded process footage, third-person editorial coverage, and the surgeon's own commentary on published research.
Long-form authority for the 90-day consult cycle
The 8 to 20 minute surgeon explainer video is the single highest-trust asset in the category. It converts the "I've been thinking about it for a year" patient into a booked consult in a way no ad, Reel or landing page can. A YouTube channel with 20 to 40 well-produced explainer videos becomes an evergreen consult engine that continues to book for years after publication. ICG's YODA product (AI-native healthcare YouTube) is built specifically for this pattern.
The review layer — the highest-scrutiny audit surface in aesthetic
Aesthetic patients audit GBP reviews more forensically than any other specialty. Review count above 100, star rating above 4.6, and a clear pattern of experience-focused reviews (procedure day, consult experience, recovery support) are the three trust signals that move enquiry rate. Review generation SOP is different for aesthetic — patients want to remain anonymous. ICG uses initial-only display, first-name-only display, and consent-first review requests as the standard.
Bottom-of-funnel capture with heavy negative-keyword governance
Google Ads for plastic surgery is a landmine of policy violations if run without governance. ICG's ad-account structure separates aesthetic keywords (which trigger scrutiny) from functional keywords (septorhinoplasty, panniculectomy, gynaecomastia — often less flagged) with different creative pools. Negative keyword lists exclude non-converting queries: "free," "cheap," "insurance," "government scheme," and specific competitor names. Meta Ads use interest-based targeting only, never body-attribute assumptions in copy.
₹ per enquiry, ₹ per consult, ₹ per case.
What actually moves the P&L.
Every plastic surgery practice we onboard has a version of the same conversation in month one — the operator wants to know what a good CPQL is. But CPQL alone tells you nothing about profitability. The three numbers that describe practice economics are: cost per qualified enquiry (CPQL), cost per booked consult (CPC) and cost per completed case (CPCC).
For rhinoplasty, our portfolio numbers are: CPQL ₹2,500-₹6,000; CPC ₹6,000-₹18,000 (after a 32-48% consult-book rate); CPCC ₹28,000-₹80,000 (after a further 18-28% case-conversion). At an average rhinoplasty case value of ₹1.4L to ₹3.2L, the CPCC to case-value ratio is 10:1 to 25:1 — which sits comfortably in profitable territory for most practice models.
For gynaecomastia — the highest-search, most-compliant male aesthetic — the numbers are tighter but the funnel is more efficient: CPQL ₹1,200-₹3,000; CPC ₹2,500-₹7,000 (42-58% book rate); CPCC ₹8,000-₹22,000. At case values of ₹75K to ₹1.6L, the ratio is 8:1 to 20:1.
For post-bariatric body work, direct-response digital is not the primary channel — the funnel is 80% B2B (bariatric-surgeon partnerships) and 20% search. Digital retainer economics are lower on the ad-spend line and higher on the partnership-management line.
The math that drives ICG's engagement model is this: for every plastic surgery client, we build a three-line P&L cell in the reporting dashboard — ad spend, agency retainer, and estimated revenue from digital-attributed cases. Practices see the ratio in month 3 and again in month 6. Practices that don't hit a 4x return by month 6 are on a diagnostic conversation with the strategy team by month 7.
38–58% lower CPQL
in 90 days. Across every specialty.
Most plastic surgery marketing agency india pitches sell on CPL. ICG sells on CPQL — Cost Per Qualified Lead — the cost of a lead that actually shows up for a consultation. The difference is often 3–4×. Here is what our 150+ healthcare clients actually pay.
90-day averages from ICG's live portfolio across Delhi NCR, Mumbai, Bangalore, Hyderabad, Pune, Chennai, and tier-2 cities. Adjust for city: metro CPQLs run 20–35% higher than tier-2 across all specialties.
Eight platforms. One intelligence layer.
Nexus CRM healthcare lead management · Beacon attribution · Hawk CRM intelligence · Phoenix clinic revenue · HealthPro 360 PMS · YODA YouTube intelligence · Agency OS live reporting · AIO Intel AEO+LLM citation tracking. Built in-house since 2018 — included in every plastic surgery marketing agency india engagement.
Hawk and YODA.
Standalone offers built for specific gaps.
Is your CRM hiding what it should be showing?
Hawk shows where your leads are leaking: which went cold, which were downgraded by automation, which are recoverable. Free Lead-Leak Audit in 48 hours.
Explore Hawk + free audit →Is your YouTube channel generating patients, or just views?
YODA connects YouTube content to consultation bookings. Patient testimonial videos generate 6.9× more consultations per view than condition explainers.
Explore YODA →Most healthcare marketing agencies treat symptoms.
ICG diagnoses root causes.
High CPL. Junk leads. Low ROAS. These are symptoms, not problems. ICG's diagnostic framework — built across 150+ healthcare engagements — maps every symptom to its actual root cause and the specific treatment that fixes it.
Every framework in this table is proprietary to ICG. Calibrated across 150+ live healthcare accounts since 2018. Full ICG methodology → · Glossary →
Read the complete guide
for your category.
Six pillar guides — each 8,000–15,000 words of original ICG methodology, CPQL benchmarks, and live client data. The depth no other Indian healthcare marketing agency publishes.
More insights at ichelonconsulting.com/insights · 250+ articles · all healthcare-only
Anonymised engagement outcomes
from ICG plastic surgery portfolio.
Situation: ISAPS-trained surgeon, 12 years post-fellowship, established consult base drifting downward as newer surgeons captured Instagram share. Consult volume declining 4% quarter-on-quarter for three quarters.
Diagnosis: No structured Instagram cadence (occasional Reels made by an in-house assistant), website credentials buried in a bio page, Google Ads account with a Meta warning on Personal Attributes policy for prior creative.
Intervention: Instagram content calendar (3 surgeon-narrated Reels/week for rhinoplasty and face-lift), homepage rebuilt around credential density and technique explainers, ad account rebuild with compliant creative pool, consult coordinator SOP installed.
Result: Monthly enquiries doubled by month 5. Consult-book rate up from 28% to 41%. Case conversion from consult held steady at 22%. Digital-attributed revenue at month 6 was 3.4x prior baseline. (ICG internal data, 2026.)
Situation: Four-branch group across Mumbai, Bangalore, Hyderabad and Chennai. Each branch had its own Instagram, its own website subdomain, and its own quality standard. Corporate marketing team wanted brand consolidation without losing branch-specific SEO equity.
Diagnosis: Duplicate content across four websites triggering cannibalisation; no consistent surgeon-per-branch credential display; ad accounts fragmented, negative keyword lists inconsistent.
Intervention: Migration to a single-domain hub with city-branch pages (each surgeon front-and-centre), single ad account with branch-level campaigns, unified content library with branch-specific overlays, GBP consolidation with correct chain-parent labelling.
Result: Aggregate organic traffic +134% at month 9. CPQL down from ₹5,200 to ₹2,800. Cross-branch consult referral tracking installed. (ICG internal data, 2026.)
Situation: Reconstructive plastic surgeon in Mumbai focused on post-weight-loss body contouring. Cases arriving sporadically via unstructured referrals from two bariatric surgeons.
Diagnosis: No formalised referral pipeline, no co-branded patient education material, no data feedback loop to the bariatric surgeons on referred-patient outcomes.
Intervention: Formal referral programme with three additional bariatric surgeons, quarterly co-branded webinar for post-op patients, co-branded landing page for panniculectomy and belt lipectomy, GLP-1 patient education content commissioned.
Result: Referred case volume up 2.6x at month 8. GLP-1 patient enquiries added a new inbound stream (30-40% of month-8 enquiries). (ICG internal data, 2026.)
Three tiers.
Solo surgeon to multi-city group.
Foundation (₹49,999/mo). Solo surgeon or single-branch aesthetic practice. Instagram cadence (3 Reels/week), monthly Google Ads management up to ₹1.5L ad spend, GBP optimisation and monthly review-generation SOP, quarterly YouTube content batch (4 videos), and a consult coordinator SOP install. Suits practices doing 20-40 procedures a month wanting to double digital-attributed case volume in 6-9 months.
Growth (₹74,999/mo). Multi-procedure practice or two-branch group. Everything in Foundation plus a second content vertical (e.g., face-lift alongside rhinoplasty), monthly YouTube batch (8 videos), higher-cadence Reels (5/week), performance content marketing (surgeon-authored long-form on the website), and a dedicated aesthetic patient coordinator playbook. Suits practices with ₹3L-₹8L monthly ad-spend headroom and cases at 40-100/month.
Scale (₹99,999+/mo). Multi-city aesthetic group, tertiary hospital plastic surgery unit, or PE-backed aesthetic chain. Custom scope — cross-branch SEO topology, surgeon-per-branch content programme, cross-city ad account architecture, ORM programme, monthly leadership dashboard. Suits groups doing ₹15L+ ad spend and 100+ cases/month.
All three tiers include the ICG plastic surgery compliance review: every piece of creative — Reel caption, ad copy, landing page headline — passes an NMC/ASCI/Meta three-layer review before publication. This is not an add-on. It is the default.
About plastic surgery marketing
agencies in India.
Yes — surgeon-authored, technique-explanatory, non-testimonial content is fully compliant. The framework we use: no before/after imagery as marketing, no outcome guarantees, no denigration of alternative surgeons or techniques, no patient testimonials used as marketing. What is allowed: educational anatomy content, surgeon-narrated technique explainers, consent-guarded process footage, and the surgeon's own commentary on published research. A 3-Reel-a-week cadence in this style is the ICG standard.
Section 6 of the NMC Professional Conduct Regulations (2002, still in force) prohibits solicitation via advertising that promises outcomes or uses patient testimonials for marketing. Before/after imagery falls into the outcome-imagery bucket and is generally treated as impermissible for marketing use. Consent-guarded before/after can appear in intra-practice educational settings, at professional-society conferences, and in peer-reviewed publications — but not as public marketing collateral. ICG's default position is: no before/after in public-facing marketing.
Keyword architecture that separates aesthetic queries (rhinoplasty cost, nose surgery consultation) from functional queries (deviated septum, septorhinoplasty) with different creative pools. Negative keyword lists that exclude non-converting queries (free, cheap, insurance, government scheme). Landing page that leads with credentials, technique and consult experience — not with cost claims or outcome imagery. Meta ads (which run under stricter Personal Attributes policy) use interest-based targeting only, and copy that assumes an active research posture ('if you're researching rhinoplasty…') rather than body-dissatisfaction copy.
As direct marketing under NMC, no. But there are three compliant patterns: (1) surgeon-narrated case narratives where the patient does not appear on camera, (2) editorial third-party coverage in press or podcast form where the patient chose to speak publicly, (3) anonymised consent-guarded review content on GBP where the patient controls their own disclosure. ICG's review-generation SOP is designed for privacy-guarded aesthetic patients — first-name-only display, initial masking, consent-first requests.
We do not publish fixed procedure prices on plastic surgery websites — the consult is the pricing event, not the website. What we do publish: a starting-from range for common procedures where the practice has agreed a floor number, and a clear explanation of what drives price variation (technique, complexity, revision vs primary, hospital vs day-care setting). This mirrors how NMC-registered practices are permitted to communicate pricing — factual, not promotional.
The default template is broken for aesthetic. Our SOP: a post-consult and post-op review request that explicitly says the review can be posted under initials, first name only, or a masked pseudonym; a copy-paste review starter phrased around consult experience and coordinator support (not surgical outcome); a follow-up cadence at day 30, day 90 and day 180 to catch patients when they feel comfortable sharing. Practices moving from a generic template to this SOP typically add 40-70% to monthly review count within a quarter.
Separate procedure pages, always. Rhinoplasty, liposuction, breast augmentation, face-lift, gynaecomastia and body contouring are all searched separately, converted by different content, and priced differently. A single aesthetic-services page ranks for none of them at any competitive level. ICG's default topology for a multi-procedure practice: one procedure page per verticals the surgeon is deeply credentialled for, with a hub page for browsing.
Functional reconstructive work — septorhinoplasty for airway, breast reduction for macromastia, panniculectomy for skin infection, hand surgery — is medical necessity and follows standard NMC advertising rules with more headroom on outcome-descriptive language ('improvement in breathing function', 'resolution of skin infection'). ASCI is still active but Meta's Personal Attributes filter is less aggressive because the copy is medically framed. ICG separates the two funnels — functional patients arrive via GP or ENT referral and via search on functional queries; aesthetic patients arrive via Instagram and search on aesthetic queries. Confusing the two on the same landing page costs conversion on both.
View sources cited on this page
- NMC Professional Conduct Regulations 2002, Section 6 — nmc.org.in
- ASCI Code for Self-Regulation of Advertising Content in India
- Meta Advertising Standards — Personal Attributes and Health & Beauty policies
- Association of Plastic Surgeons of India (APSI) practice guidelines
- International Society of Aesthetic Plastic Surgery (ISAPS) India chapter
- Industry healthcare marketing benchmarks
- ICG portfolio data (n=9 plastic surgery engagements, Sep 2025-Aug 2026)
Ready to build a
plastic surgery marketing engine?
Start with a 30-minute plastic surgery growth diagnostic. For solo aesthetic surgeons, multi-branch groups and hospital plastic surgery units across India.
